Insights Exchange – How Can We Better Predict Clinical Success Before the Clinic?

11:40 am - Wednesday 2nd December 2026

  • Which preclinical endpoints, biomarkers, and model characteristics are most consistently associated with successful clinical outcomes?
  • How can organisations use clinical observations, imaging, and translational data to improve confidence in model-derived decisions and reduce late-stage risk?
  • What are the most common reasons promising preclinical programmes fail in patients, and how can model strategies be refined to improve predictability?
  • Audience Q&As

Speakers:

Director, Non-Clinical Projects Operations
Eli Lilly & Co.
Vice President & Head, Discovery Oncology
Immuneering Corp.
Chief Scientific Officer
Hemispherian
Unit Head, Target & Disease Biology, Discovery Oncology
Roche